Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001635088-26-000065

President & Immunovant CEO sold 200,000 shares at $30.27 ($6,054,000)

  • President & Immunovant CEO gave up 34,483 shares (to pay taxes)
  • President & Immunovant CEO acquired 200,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Venker Eric · President & Immunovant CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-05-20 Shares withheld for taxes : show line 1 in the form 10b5-1 −34,483 $32.41 $1,117,594 1,613,063 D
2026-05-22 Exercise or conversion : show line 2 in the form 10b5-1 +200,000 $3.85 $770,000 1,813,063 D
2026-05-22 Sale : show line 3 in the form 10b5-1 −200,000 $30.27 $6,054,000 1,613,063 D
Open-market sales · 200,000 sh · avg $30.27 · $6,054,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-05-22 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) −200,000 4,444,834 D
Loading xslF345X06/wk-form4_1779488744.xml…